Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible Light Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106467481B enables visible-light synthesis of indole ketones without transition metals, offering cost reduction and high purity for pharmaceutical manufacturing supply chains.
Patent CN114213254B details a novel photoredox method for beta-nitroketones. Enables cost reduction in pharmaceutical intermediate manufacturing with high yields.
Patent CN112142680B details a metal-free photocatalytic route for 3-trifluoroalkylquinoxalinones, offering cost-effective and scalable manufacturing for pharmaceutical intermediates.
Novel visible light iron catalysis method for 4-arylbutyronitrile. Offers 100% atom economy and mild conditions for scalable pharmaceutical intermediate manufacturing.
Patent CN112939883B reveals a metal-free visible light method for 1,3-oxazolidines. Achieve cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN118702710B introduces catalyst-free visible light synthesis enabling sustainable scale-up of high-purity organoboron compounds with significant cost reduction potential.
Patent CN108774129A enables green synthesis of α,β-un saturated carboxylate derivatives under mild conditions with environmental benefits enhancing supply chain reliability for pharmaceutical manufacturing.
Novel visible-light photocatalytic method for sulfuryl gamma-lactone synthesis enabling high-purity pharmaceutical intermediates with improved supply chain reliability and cost efficiency.
Patent CN109053625B enables mild visible-light synthesis of benzothiazole derivatives eliminating transition metals to reduce costs and enhance supply chain reliability for pharmaceutical intermediates.
Patent CN117088826B enables visible-light synthesis of polysubstituted oxazoles without transition metals, offering greener manufacturing and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN104844651A enables green synthesis of fluorinated phenanthridine derivatives with mild conditions, reducing waste and enhancing supply chain reliability for fine chemical manufacturing.
Novel visible light-mediated synthesis achieves high-purity API intermediates with mild conditions and scalable production for reliable supply chain.
Patent CN110590788B enables high-purity 2-acyl-pyrroloindole API intermediates through visible-light catalysis, reducing manufacturing costs and lead times.
Patent CN111039737B enables mild visible-light catalysis for high-purity pharmaceutical intermediates with scalable production reducing manufacturing costs.
Novel visible-light catalyzed synthesis of 3-aryl-2H-indazoles enables high-purity pharmaceutical intermediates with reduced manufacturing costs and faster scale-up.
Discover metal-free, high-yield 3-selenofuran synthesis using visible light. Eliminate transition metals, reduce costs, and ensure supply chain stability for pharmaceutical intermediates.
Solve piperazine cyanation challenges with metal-free visible light catalysis. 83% yield, air atmosphere, no expensive equipment. Scale to 100MT/yr.
Discover how visible light photocatalysis enables safer, higher-yield synthesis of 3-acyl spirotrienones for pharmaceutical intermediates. Reduce supply chain risks.
Discover how visible light catalysis enables 90% yield 3-alkylquinoxaline-2(1H)-ketone synthesis at room temperature, reducing production costs and safety risks for pharmaceutical intermediates.
Eliminate expensive catalysts and harsh conditions in aryltrimethylstannane production. 95% yields, metal-free process, and scalable manufacturing for pharmaceutical intermediates.